Don't miss an issue! Renew/subscribe for FREE today.

Henry Schein Climbs to #292 on the FORTUNE 500

Posted on Monday, June 2, 2014

MELVILLE, N.Y., June 2, 2014 /PRNewswire/ -- Henry Schein, Inc. (NASDAQ: HSIC), the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners, announced today that it has climbed to #292 on the FORTUNE 500® ranking of America's largest corporations, marking its 10th anniversary as a FORTUNE 500 company.  The Company was ranked #296 on the 2013 list.

Henry Schein had net sales in 2013 of $9.6 billion, up from $4.1 billion in 2004 when it first debuted on the FORTUNE 500 at #497.  Since Henry Schein became a public company in 1995, the Company's revenues have grown at a compound annual rate of approximately 16 percent.

The FORTUNE 500 list is an annual ranking of America's largest corporations based on total revenues for their respective fiscal years. Included in the survey are companies that are incorporated in the U.S. and operate in the U.S. and file financial statements with a government agency.

"Our continued climb up the Fortune 500 rankings for a decade underscores the soundness of our long-term strategic vision for the Company," said Stanley M. Bergman, Chairman of the Board and Chief Executive Officer of Henry Schein.  "Our continued global growth is the result of the shared commitment and values of nearly 17,000 Team Schein Members, who are dedicated to providing our customers with the very best solutions and service, and to continually raising the bar for our Company's performance year after year."

Henry Schein has also been a FORTUNE Most Admired company for 13 consecutive years.  In 2014, the Company ranked #1 on the 2014 FORTUNE Most Admired list in the Wholesalers: Health Care industry category, and first in each of the nine sub-categories used to create the rankings, which are: Innovation, People Management, Use of Corporate Assets, Social Responsibility, Quality of Management, Financial Soundness, Long-Term Investment, Quality of Products/Services, and Global Competitiveness.

Recent Headlines

© 2024 BroadcastMed LLC | Privacy Policy